ЭФФЕКТИВНОСТЬ ФИРМАГОНА ПРИ РАСПРОСТРАНЕННОМ РАКЕ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ ПОСЛЕ ПРОГРЕССИРОВАНИЯ НА СТАНДАРТНОЙ СХЕМЕ МАБ: РАЗБОР КЛИНИЧЕСКОГО СЛУЧАЯ

Prostate cancer is the most common form of cancer in men in Western countries and in some countries is in second place in the list of leading causes of cancer death in men. About 300 000 new cases of prostate cancer registered annually in Europe. In the world this number rises to 670,000 new cases. Prostate cancer in Russia takes 4 th place after lung cancer, gastric cancer and non-melanoma skin tumors. . Prostate cancer took 1st place in the list of the increase of incidence in Russia during the period 1999-2009 (by 2.8 times). Prostate tumors account for 6.9% of all malign tumors in men. Mortality due to prostate cancer is 10.4 per 100 000 in male population.